Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaMarine is a Norwegian biotechnology company specializing in the research, development, and manufacture of advanced marine-derived lipid ingredients. Headquartered in Terøy, the company is a global leader in producing high-quality omega-3 concentrates using sustainable raw materials such as squid and cod by-products. Their proprietary processing technology includes molecular distillation and enzymatic esterification to create potent docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) oils for the nutraceutical and functional food markets. PharmaMarine is notably recognized for its Calamarine product line, which pioneered the use of squid as a sustainable source of DHA. The company maintains a strong commitment to environmental responsibility, holding multiple sustainability certifications for its production processes. Their products support a wide range of health applications, including cardiovascular, cognitive, and ophthalmic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaMarine.